Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

SMMT

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateTimeSourceHeadlineSymbolCompany
01/23/20235:04AMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:SMMTSummit Therapeutics Inc
01/20/20234:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
01/20/20237:00AMBusiness WireSummit Therapeutics Closes Deal with Akeso Inc. to In-License Breakthrough Innovative Bispecific AntibodyNASDAQ:SMMTSummit Therapeutics Inc
01/09/20233:35PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
01/05/20233:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SMMTSummit Therapeutics Inc
01/05/20233:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SMMTSummit Therapeutics Inc
01/05/20233:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SMMTSummit Therapeutics Inc
01/05/20236:00AMBusiness WireSummit Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare ConferenceNASDAQ:SMMTSummit Therapeutics Inc
12/27/20223:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
12/21/20224:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
12/21/20223:52PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:SMMTSummit Therapeutics Inc
12/13/20223:07PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SMMTSummit Therapeutics Inc
12/09/20224:25PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SMMTSummit Therapeutics Inc
12/08/20225:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SMMTSummit Therapeutics Inc
12/06/20223:57PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
12/06/20223:46PMTipRanksSummit Therapeutics Explodes Up on Licensing DealNASDAQ:SMMTSummit Therapeutics Inc
12/06/20226:30AMGlobeNewswire Inc.Summit Therapeutics Partners with Akeso Inc. in Deal for Up to $5 Billion to In-License Breakthrough Innovative Bispecific AntibodyNASDAQ:SMMTSummit Therapeutics Inc
11/17/20223:25PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SMMTSummit Therapeutics Inc
11/17/20223:15PMGlobeNewswire Inc.Summit Therapeutics Appoints Experienced Clinical Leader Dr. Alessandra Cesano to its Board of DirectorsNASDAQ:SMMTSummit Therapeutics Inc
11/09/20223:25PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SMMTSummit Therapeutics Inc
11/09/20227:30AMGlobeNewswire Inc.Summit Therapeutics Inc. Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2022NASDAQ:SMMTSummit Therapeutics Inc
10/20/20224:15PMGlobeNewswire Inc.Summit Therapeutics Presents Ri-CoDIFy Trial Results for Microbiome-Sparing Ridinilazole at IDWeek 2022NASDAQ:SMMTSummit Therapeutics Inc
10/13/20227:00AMGlobeNewswire Inc.Summit Therapeutics to Present Ri-CoDIFy Trial Results for Microbiome-Sparing Ridinilazole at IDWeek 2022NASDAQ:SMMTSummit Therapeutics Inc
10/04/20227:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
10/03/20223:36PMGlobeNewswire Inc.Summit Therapeutics Appoints Dr. Robert Booth, Renowned Executive and Scientific Leader, to its Board of DirectorsNASDAQ:SMMTSummit Therapeutics Inc
08/18/20223:43PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SMMTSummit Therapeutics Inc
08/18/20223:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SMMTSummit Therapeutics Inc
08/17/20223:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SMMTSummit Therapeutics Inc
08/16/20223:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
08/11/20223:18PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT